Site Map
Product Pages Catalogue Numbers 0701 - 0800
| Cat. No. | Product Name & Pharmacological Action |
|---|---|
| 0701 | 3'-Fluorobenzylspiperone maleate |
D2-like receptor ligand |
|
| 0702 | BTCP maleate |
Potent dopamine uptake inhibitor |
|
| 0703 | Anpirtoline hydrochloride |
| Highly potent 5-HT1B agonist. Also 5-HT3 antagonist | |
| 0705 | L-701,252 |
| NMDA antagonist, acts glycine site | |
| 0706 | 7-Hydroxy-DPAT hydrobromide |
Dopamine agonist (D3 ³ D2 > D4) |
|
| 0708 | Hydroxypropyl-β-cyclodextrin |
| Solubilization agent | |
| 0711 | MAP4 |
| Potent group II mGlu agonist. Also specific group III mGlu antagonist | |
| 0713 | Cyclothiazide |
| AMPA selective desensitization inhibitor | |
| 0719 | 7-Hydroxy-PIPAT maleate |
D3 agonist (D3 > D2) |
|
| 0721 | Aminopotentidine |
| H2 antagonist | |
| 0722 | N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide |
| Nitroxyl precursor | |
| 0723 | Tetrindole mesylate |
| MAO-A inhibitor | |
| 0724 | Pirlindole mesylate |
| MAO-A inhibitor | |
| 0725 | BU 224 hydrochloride |
| Potent, selective I2 ligand. Putative antagonist | |
| 0726 | BU 239 hydrochloride |
| Potent, highly selective I2 ligand | |
| 0727 | Pyrrolidinedithiocarbamate ammonium |
| Inhibits NF-κB, prevents increase in NOS mRNA | |
| 0728 | RS 23597-190 hydrochloride |
| 5-HT4 antagonist | |
| 0729 | Imetit dihydrobromide |
| Standard H3 and H4 agonist (H3 > H4) | |
| 0730 | 4-Phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride |
DA release inhibitor |
|
| 0731 | Sulfisoxazole |
| Endothelin ETA antagonist | |
| 0735 | 3-Bromo-7-nitroindazole |
| Selective nNOS inhibitor | |
| 0736 | 2-[1-(4-Piperonyl)piperazinyl]benzothiazole |
| 5-HT4 agonist. Also 5-HT3 antagonist | |
| 0737 | 2-Iodomelatonin |
| High affinity melatonin agonist | |
| 0740 | Naltrindole hydrochloride |
| δ selective non-peptide antagonist | |
| 0741 | GF 109203X |
| Protein kinase C inhibitor | |
| 0742 | L-689,560 |
| Very potent NMDA antagonist | |
| 0743 | DPPE fumarate |
| Inhibitor of histamine binding at the intracellular binding site | |
| 0744 | Ceramide |
| Ser/Thr protein phosphatase activator | |
| 0746 | Zinc protoporphyrin IX |
| Haem oxygenase and guanylyl cyclase inhibitor | |
| 0747 | Tin protoporphyrin IX dichloride |
| Haem oxygenase inhibitor | |
| 0748 | 4-IBP |
| σ ligand, σ1 > σ2 | |
| 0749 | Dihydrosphingosine |
| Protein kinase C inhibitor | |
| 0750 | PG-9 maleate |
Presynaptic cholinergic modulator |
|
| 0751 | SM-21 maleate |
Presynaptic cholinergic modulator |
|
| 0752 | Clobenpropit dihydrobromide |
| Highly potent H3 antagonist and H4 partial agonist | |
| 0754 | N-Benzylnaltrindole hydrochloride |
| δ2 selective non-peptide antagonist | |
| 0756 | SIN-1 chloride |
| Water-soluble NO donor | |
| 0757 | Vinpocetine |
| Na+ channel blocker | |
| 0759 | Castanospermine |
| Glucosidases α and b inhibitor | |
| 0760 | AM 580 |
| Retinoic acid agonist | |
| 0761 | TTNPB |
| Retinoic acid agonist | |
| 0763 | N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide |
| σ1 selective ligand | |
| 0764 | SNC 80 |
| Highly selective non-peptide δ agonist | |
| 0767 | Bifemelane hydrochloride |
| MAO-A and MAO-B inhibitor | |
| 0768 | Riluzole hydrochloride |
| Glutamate release inhibitor/GABA uptake inhibitor | |
| 0770 | GBLD 345 |
| High affinity benzodiazepine agonist | |
| 0771 | L-NMMA acetate |
| Non-selective NOS inhibitor | |
| 0772 | Carboxy-PTIO, potassium salt |
| Stable, water-soluble deactivator of NO | |
| 0773 | Memantine hydrochloride |
| NMDA antagonist, acts ion channel site | |
| 0775 | (+)-UH 232 maleate |
D2-like autoreceptor antagonist. D3 partial agonist. |
|
| 0776 | (S)-Methylisothiourea sulfate |
| Highly selective iNOS inhibitor | |
| 0778 | ICI 199,441 hydrochloride |
| Potent κ agonist | |
| 0779 | Iodophenpropit dihydrobromide |
| Potent, selective H3 antagonist | |
| 0780 | NCS-382 |
| Antagonist of γ hydroxybutyric acid | |
| 0781 | L-694,247 |
| 5-HT1D agonist | |
| 0782 | 2-Chloro-11-(4-methylpiperazino)dibenz[b,f]oxepin maleate |
| D2-like antagonist. Displays some D4 selectivity | |
| 0783 | N-Methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]phenylacetamide hydrochloride |
| Selective κ agonist | |
| 0784 | Ketotifen fumarate |
| H1 antagonist | |
| 0785 | SB 203186 hydrochloride |
| 5-HT4 antagonist | |
| 0786 | Edaravone |
| Anti-ischaemic and antioxidant | |
| 0787 | Aminoguanidine hydrochloride |
| Irreversible iNOS inhibitor | |
| 0788 | 3-Aminobenzamide |
| PARP inhibitor | |
| 0789 | (±)-Anatoxin A fumarate |
Nicotinic agonist |
|
| 0790 | Rilmenidine hemifuramate |
α2 agonist. Also I1 ligand |
|
| 0791 | Antazoline hydrochloride |
| Imidazoline ligand | |
| 0792 | Efaroxan hydrochloride |
α2 antagonist and I1, I3 ligand |
|
| 0793 | Idazoxan hydrochloride |
α2 antagonist, I2 ligand |
|
| 0794 | DIPPA hydrochloride |
| Selective irreversible κ antagonist | |
| 0796 | (R)-Baclofen |
| Active enantiomer of Cat. No. 0417 | |
| 0797 | 8-Hydroxy-PIPAT oxalate |
| High affinity 5-HT1A agonist | |
| 0800 | 7-NINA |
| Sodium salt of (Cat. No. 0602) | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | All |
[top]